Skip to main content

Female Sexual Dysfunction (FSD)

Female sexual dysfunction (FSD) refers to a range of conditions that can hinder a woman’s sexual response, enjoyment, and fulfillment. It can involve issues in any stage of sexual response, such as desire, arousal, orgasm, or pain during intercourse. The causes can be complex and multifaceted, including psychological, physiological, and interpersonal factors.

Types of Female Sexual Dysfunction

Desire Disorders

A lack of sexual interest or desire, which can be persistent or recurrent. Common causes include:

  • Hormonal changes (e.g., menopause, postpartum, thyroid disorders)
  • Stress and anxiety
  • Certain medications (e.g., antidepressants, birth control pills)
  • Relationship issues
  • Low self-esteem or body image concerns

Arousal Disorders

When a woman wants to engage in sexual activity but experiences difficulty becoming physically aroused. This can manifest as:

  • Lack of lubrication
  • Reduced sensation or pleasure
  • Difficulty maintaining arousal

Possible causes include:

  • Medical conditions (e.g., diabetes, cardiovascular disease)
  • Hormonal imbalances
  • Psychological factors (e.g., stress, depression, trauma)

Orgasmic Disorders

Delayed, infrequent, or absent orgasms, or reduced intensity of orgasmic sensations. Contributing factors include:

  • Pelvic floor dysfunction
  • Certain medications
  • Psychological barriers (e.g., stress, past trauma, performance anxiety)

Pain Disorders (Dyspareunia or Vaginismus)

Pain during intercourse can be caused by:

  • Endometriosis or pelvic inflammatory disease
  • Vaginal infections
  • Hormonal changes affecting vaginal dryness
  • Past trauma or anxiety-related muscle tension

Causes of Female Sexual Dysfunction

Biological Factors

  • Hormonal imbalances (e.g., decreased estrogen post-menopause)
  • Medical conditions (e.g., diabetes, cardiovascular disease, thyroid disorders)
  • Medications (e.g., antidepressants, blood pressure medications)
  • Substance use (e.g., alcohol, smoking, recreational drugs)

Psychological Factors

  • Stress, anxiety, and depression
  • Past trauma or sexual abuse
  • Low self-esteem or body image issues

Relationship Issues

  • Lack of trust or emotional connection
  • Poor communication
  • Unresolved conflicts or dissatisfaction

Diagnosis of Female Sexual Dysfunction

Diagnosing FSD involves a thorough evaluation, including medical history, psychological assessment, and relationship factors.

Screening Questionnaires

Several validated tools are used to assess FSD:

Female Sexual Function Index (FSFI)
  • Evaluates sexual desire, arousal, lubrication, orgasm, satisfaction, and pain
  • A total score of 26.55 or lower generally indicates sexual dysfunction
Female Sexual Distress Scale-Revised (FSDS-R)
  • Measures distress related to sexual dysfunction
  • Scores above 11 suggest clinically significant distress
Sexual Interest and Desire Inventory–Female (SIDI-F)
  • Focuses on hypoactive sexual desire disorder (HSDD)
  • Scores range from 0 to 51, with lower scores indicating greater dysfunction
Brief Sexual Symptom Checklist for Women (BSSC-W)
  • A quick four-question screening tool
  • If any response is “yes,” further evaluation is recommended
Sexual Quality of Life-Female (SQOL-F)
  • Assesses the impact of sexual dysfunction on a woman’s quality of life
  • Higher scores indicate better sexual well-being

Physical Examination & Assessment

A comprehensive physical exam helps identify medical conditions contributing to FSD.

General Health Examination

  • Vital signs: Blood pressure, heart rate, BMI
  • Thyroid assessment: Thyroid dysfunction affects hormone levels and libido
  • Neurological exam: Tests nerve function related to sexual sensation

Gynecological Examination

  • Pelvic exam to assess vaginal health, lubrication, and signs of infections or atrophy
  • Bimanual exam to detect ovarian cysts, fibroids, or endometriosis
  • Speculum exam for cervix and vaginal wall evaluation

Pelvic Floor Muscle Exam

  • Pelvic muscle strength assessment (e.g., Kegels)
  • Trigger point detection (muscle spasms linked to vaginismus or dyspareunia)

Hormonal and Breast Exam

  • Estrogen and testosterone levels to assess hormone-related FSD
  • Breast exam to screen for hormone-sensitive changes

Laboratory Tests for Female Sexual Dysfunction

Hormonal Tests

  • Estradiol & Testosterone: Affect libido and vaginal health
  • FSH & LH: Help assess menopause status
  • Prolactin: High levels can suppress libido
  • Thyroid hormones (TSH, Free T4, Free T3): Linked to mood and energy levels

Metabolic Tests

  • Fasting glucose & Hemoglobin A1c: Diabetes affects nerve function and circulation
  • Lipid profile: Poor circulation impacts sexual response

Vitamin and Mineral Levels

  • Vitamin D & B12: Deficiencies impact energy and mood
  • Iron (Ferritin): Anemia can contribute to fatigue and low libido

Infection Screening (If Symptoms Are Present)

  • Urine analysis: Detects urinary tract infections
  • STI panel: Screens for chlamydia, gonorrhea, syphilis, HIV

Treatment Options for Female Sexual Dysfunction

Lifestyle Changes

  • Regular exercise: Improves circulation and body image
  • Balanced diet: Supports hormonal health
  • Stress management: Meditation, therapy, or relaxation techniques

Psychological and Relationship Therapy

  • Sex therapy and counseling
  • Cognitive behavioral therapy (CBT)
  • Couples therapy to address relationship concerns

Medications

  • Flibanserin (Addyi): FDA-approved for HSDD in premenopausal women (Not approved in Canada)
  • Bremelanotide (Vyleesi): Injection for HSDD (Not approved in Canada)
  • Hormone therapy: Estrogen and testosterone (limited off-label use in Canada)

Pelvic Floor Physical Therapy

  • Kegel exercises & biofeedback therapy
  • Manual therapy for muscle relaxation

Devices

  • Vibrators and dilators for arousal and pain management
  • Pulsed Electromagnetic Field (PEMF) devices to improve blood flow

Alternative & Complementary Therapies

  • Acupuncture for circulation and stress relief
  • Herbal supplements (e.g., maca root, L-arginine) with mixed results

Surgical Treatments (If Necessary)

  • Surgical correction for structural abnormalities
  • Laser therapy for vaginal atrophy

Female Sexual Dysfunction Treatment in Canada

  • Limited medication approvals: No flibanserin or bremelanotide
  • Testosterone therapy is off-label
  • Estrogen therapy is approved for vaginal atrophy
  • Lubricants and moisturizers available OTC

The Use of PRP for Sexual Dysfunction

Overview of PRP in Female Sexual Dysfunction

Platelet-Rich Plasma (PRP) therapy is being explored as a treatment for female sexual dysfunction (FSD). While it remains experimental and is not yet widely approved for this use, some studies suggest potential benefits.

PRP therapy involves drawing a patient’s blood, processing it to concentrate the platelets, and then injecting the enriched plasma into targeted areas. For sexual health, PRP is typically injected into the clitoris, anterior vaginal wall (near the G-spot), or around the urethra. The growth factors in PRP may help with tissue regeneration, increased blood flow, and enhanced sensation.

Potential Benefits of PRP for FSD

  • Improved Arousal and Sensation: Enhanced blood circulation and nerve sensitivity may improve sexual response.
  • Increased Lubrication: PRP may help with vaginal dryness, particularly for postmenopausal women.
  • Pain Reduction: Some practitioners believe PRP can aid in healing tissue damage related to dyspareunia (painful intercourse) and vulvodynia.

Evidence and Limitations

  • Lack of Large-Scale Studies: While small studies and anecdotal reports exist, clinical evidence is limited.
  • Unclear Mechanisms: The exact way PRP enhances sexual function is still unknown.
  • Safety and Standardization: PRP is generally considered safe since it uses the patient’s own blood, but best practices for dosage, frequency, and injection sites are not yet standardized.

Current Recommendations

PRP for FSD is still in its experimental stages. Women should consider traditional treatments like lifestyle changes, hormone therapy, or physical therapy before opting for PRP. If pursued, it should be administered by a trained clinician with experience in PRP and female sexual health.

Key Studies and References

  • Sharp, C. A., & Dorton, H. M. (2017). Platelet-rich plasma for the treatment of female sexual dysfunction: A review of the current evidence. Sexual Medicine Reviews, 5(4), 475-479.
  • Turnbull, C., & Greco, N. J. (2021). PRP and female sexual dysfunction: An emerging treatment in need of research. Journal of Women’s Health, 30(4), 467-472.

The HIFEM Chair for Female Sexual Dysfunction

What is the HIFEM Chair?

High-intensity focused electromagnetic (HIFEM) therapy, commonly delivered via the Emsella chair, was initially developed for urinary incontinence but is now being explored for its potential benefits in female sexual function. HIFEM technology stimulates pelvic floor muscles, producing contractions that help strengthen the muscles supporting the bladder, uterus, and vaginal canal.

Potential Benefits of HIFEM for Female Sexual Dysfunction

  • Pelvic Floor Strengthening: May improve arousal and orgasmic function by enhancing muscle tone.
  • Increased Blood Flow: Improved circulation to the pelvic region can enhance sexual response and lubrication.
  • Pain Reduction: Some women with dyspareunia (painful intercourse) may benefit from stronger pelvic floor support.

Evidence and Limitations

  • Research on FSD is Limited: Most studies focus on urinary incontinence, though some report secondary benefits for sexual function.
  • Best for Pelvic Floor-Related FSD: Women with hormone-related or psychological causes of FSD may not experience the same benefits.
  • Effects May Be Temporary: Some studies suggest maintenance sessions are needed for sustained improvement.

Key Studies and References

  • Samraj, K., & Adams, J. (2020). High-intensity focused electromagnetic field therapy (Emsella chair) for pelvic floor dysfunction and its impact on sexual function. Journal of Pelvic Medicine, 16(4), 234-239.
  • Wallace, S. L., & Miller, D. S. (2019). Electromagnetic pelvic floor therapy for female sexual dysfunction: A review.Journal of Sexual Medicine, 16(10), 1438-1443.

The Morpheus8V for Female Sexual Dysfunction

What is Morpheus8V?

Morpheus8V is a non-surgical vaginal rejuvenation treatment that combines microneedling with radiofrequency (RF) energy. It is designed to stimulate collagen and elastin production in vaginal tissues, potentially enhancing vaginal health and sexual function.

Potential Benefits of Morpheus8V

  • Increased Vaginal Tightness: May improve firmness and elasticity, enhancing sexual satisfaction.
  • Enhanced Lubrication: Can alleviate vaginal dryness and discomfort during intercourse.
  • Improved Sensation: RF energy may heighten nerve sensitivity, leading to improved arousal.
  • Pain Reduction: May help with dyspareunia by revitalizing vaginal tissues.

Considerations

  • Generally Safe: The procedure has minimal downtime, but individual results vary.
  • Multiple Sessions Required: Typically, a series of treatments spaced weeks apart is needed.
  • Combination with Other Therapies: Morpheus8V may be used alongside hormone therapy or pelvic floor therapy for optimal results.

Key Studies and References

  • Modern Women’s Health. Morpheus8V Vaginal Rejuvenation.
  • Astra Medicare. A Guide to Morpheus8V and Women’s Vaginal Health.

The ESWL ED1000 for Female Sexual Dysfunction

What is ESWL ED1000?

Extracorporeal Shock Wave Therapy (ESWT), particularly the ED1000 device, has been widely studied for male erectile dysfunction. It delivers low-intensity shock waves to improve blood flow and tissue regeneration. Its use in female sexual dysfunction is still in early research stages.

Potential Benefits for Female Sexual Dysfunction

  • Improved Blood Flow: May enhance circulation in vaginal tissues, potentially benefiting arousal and sensitivity.
  • Tissue Regeneration: The regenerative effects of ESWT might help with conditions like vaginal atrophy.
  • Increased Sensitivity: Some anecdotal reports suggest benefits for nerve function and sensation.

Considerations

  • Lack of FDA Approval: ESWT for FSD is experimental and not FDA-approved.
  • Limited Clinical Evidence: While promising in men, research on its effects in women is minimal.
  • More Studies Needed: Further clinical trials are required to confirm its effectiveness for FSD.

Key Studies and References

  • European Urology. Low-intensity extracorporeal shock wave treatment for erectile dysfunction.
  • Turnbull, C., & Greco, N. J. (2021). PRP and female sexual dysfunction: An emerging treatment in need of research. Journal of Women’s Health, 30(4), 467-472.

Conclusion

Many emerging treatments, including PRP, HIFEM therapy, Morpheus8V, and ESWT, show potential for improving female sexual dysfunction. However, most remain experimental with limited large-scale clinical evidence. Women considering these therapies should consult with a healthcare provider specializing in sexual health to explore evidence-based treatments and determine the best approach for their specific needs.

A future FAQ section will provide additional insights into common concerns about FSD and its treatments.

Frequently Asked Questions

What are the common symptoms of FSD?

Symptoms of FSD vary but may include:

  • Low or absent sexual desire
  • Difficulty becoming aroused or maintaining arousal
  • Lack of orgasm or delayed orgasm
  • Pain during intercourse (dyspareunia) or involuntary muscle spasms (vaginismus)
  • Emotional distress related to sexual difficulties

What causes female sexual dysfunction?

FSD can result from a variety of factors, including:

  • Hormonal changes (e.g., menopause, pregnancy, thyroid disorders)
  • Medical conditions (e.g., diabetes, cardiovascular disease, chronic pain)
  • Psychological factors (e.g., stress, depression, anxiety, past trauma)
  • Medications (e.g., antidepressants, birth control pills, blood pressure medications)
  • Relationship issues (e.g., lack of emotional connection, unresolved conflicts)

How is FSD diagnosed?

A healthcare provider may diagnose FSD through:

  • A detailed medical and sexual history
  • Physical and pelvic exams
  • Laboratory tests (hormonal, metabolic, and vitamin levels)
  • Validated questionnaires, such as the Female Sexual Function Index (FSFI)

What treatment options are available for FSD?

Treatment depends on the underlying cause and may include:

  • Lifestyle changes (regular exercise, stress management, a balanced diet)
  • Psychological and relationship therapy (sex therapy, cognitive behavioral therapy, couples counseling)
  • Medications (hormone therapy, flibanserin, bremelanotide, lubricants, and moisturizers)
  • Pelvic floor physical therapy (Kegel exercises, biofeedback, manual therapy)
  • Medical devices (vibrators, electromagnetic stimulation, PRP therapy)
  • Alternative treatments (acupuncture, herbal supplements, mindfulness techniques)

Is there a cure for FSD?

FSD is often a manageable condition rather than a curable one. With the right treatment approach, many women experience significant improvements in their sexual health and overall well-being.

What are the differences between FSD treatment in the U.S. and Canada?

  • In Canada, medications like flibanserin (Addyi) and bremelanotide (Vyleesi) are not approved.
  • Testosterone therapy is available but used off-label.
  • Estrogen therapy is approved for menopausal symptoms but not specifically for sexual desire.
  • Non-prescription options like lubricants and vaginal moisturizers are widely available.

Can pelvic floor exercises help with FSD?

Yes, strengthening the pelvic floor muscles through Kegel exercises and biofeedback therapy can improve blood circulation, arousal, and orgasmic response while reducing pain associated with intercourse.

What role does hormone therapy play in treating FSD?

  • Estrogen therapy (vaginal creams, rings, or tablets) can help with vaginal dryness and discomfort.
  • Testosterone therapy (off-label in Canada) may help boost libido in postmenopausal women but requires medical supervision.

When should I see a doctor about sexual dysfunction?

You should consult a healthcare provider if:

    • Sexual concerns persist for more than a few months.
    • Symptoms cause emotional distress or affect your relationships.
    • You experience pain, discomfort, or noticeable changes in sexual function.
    • You suspect a medication or medical condition may be contributing to the issue.

Where can I find more information or support?

  • Speak with a gynecologist, urologist, or sex therapist.
  • Check reputable sources like the North American Menopause Society (NAMS), International Society for the Study of Women’s Sexual Health (ISSWSH), and Sexual Medicine Society of North America (SMSNA).
  • Join support groups or online communities for women experiencing similar concerns.